Chemical Formula: C44H71NO13

Chemical Formula C44H71NO13

Found 15 metabolite its formula value is C44H71NO13

3-<4)-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)>oxy>olean-12-en-28-oic acid|3-{[O-beta-D-galactopyranosyl-(1[*]4)-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)]oxy}olean-12-en-28-oic acid

3-<4)-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)>oxy>olean-12-en-28-oic acid|3-{[O-beta-D-galactopyranosyl-(1[*]4)-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)]oxy}olean-12-en-28-oic acid

C44H71NO13 (821.4925155999999)


   

lotoidoside E|oleanolic acid 3-O-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranoside

lotoidoside E|oleanolic acid 3-O-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranoside

C44H71NO13 (821.4925155999999)


   

3-O-[beta-D-Galactopyranosyl-(1?4)-2-acetamido-2-deoxy-beta-D-glucopyranside]-3beta-3-Hydroxy-12-oleanen-28-oic acid

3-O-[beta-D-Galactopyranosyl-(1?4)-2-acetamido-2-deoxy-beta-D-glucopyranside]-3beta-3-Hydroxy-12-oleanen-28-oic acid

C44H71NO13 (821.4925155999999)


   
   
   
   

Tacrolimus

Tacrolimus monohydrate

C44H71NO13 (821.4925155999999)


C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C146638 - Calcineurin Inhibitor D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D016559 - Tacrolimus COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D004791 - Enzyme Inhibitors > D065095 - Calcineurin Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Tacrolimus monohydrate (FK506 monohydrate), a macrocyclic lactone, binds to FK506 binding protein (FKBP) to form a complex and inhibits calcineurin phosphatase, which inhibits T-lymphocyte signal transduction and IL-2 transcription. Immunosuppressive properties[1].

   
   
   

(6Z,9Z,12Z,15Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradeca-4,8,12-trien-2-yl]octadeca-6,9,12,15-tetraenamide

(6Z,9Z,12Z,15Z)-N-[(4E,8E,12E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradeca-4,8,12-trien-2-yl]octadeca-6,9,12,15-tetraenamide

C44H71NO13 (821.4925155999999)


   

(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydec-4-en-2-yl]docosa-4,7,10,13,16,19-hexaenamide

(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydec-4-en-2-yl]docosa-4,7,10,13,16,19-hexaenamide

C44H71NO13 (821.4925155999999)


   

(3Z,6Z,9Z,12Z,15Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradeca-4,8-dien-2-yl]octadeca-3,6,9,12,15-pentaenamide

(3Z,6Z,9Z,12Z,15Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradeca-4,8-dien-2-yl]octadeca-3,6,9,12,15-pentaenamide

C44H71NO13 (821.4925155999999)


   

(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide

(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide

C44H71NO13 (821.4925155999999)


   

(5Z,8Z,11Z,14Z,17Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydodeca-4,8-dien-2-yl]icosa-5,8,11,14,17-pentaenamide

(5Z,8Z,11Z,14Z,17Z)-N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydodeca-4,8-dien-2-yl]icosa-5,8,11,14,17-pentaenamide

C44H71NO13 (821.4925155999999)